Development of novel darunavir amorphous solid dispersions with mesoporous carriers

被引:13
作者
Zolotov, Sergey A. [1 ]
Demina, Natalia B. [2 ]
Zolotova, Anna S. [1 ]
Shevlyagina, Natalia V. [3 ]
Buzanov, Grigorii A. [4 ]
Retivov, Vasilii M. [5 ]
Kozhukhova, Evgeniia I. [5 ]
Zakhoda, Oleg Y. [1 ]
Dain, Igor A. [1 ]
Filatov, Andrei R. [1 ]
Cheremisin, Alexander M. [1 ]
机构
[1] Amedart LLC, Moscow, Russia
[2] Sechenov First Moscow State Med Univ, Inst Pharm, Dept Pharmaceut Technol, Moscow, Russia
[3] Gamaleya Fed Res Ctr Epidemiol & Microbiol, Moscow, Russia
[4] NRC Kurchatov Inst, Inst Chem Reagents & High Purity Chem Subst, Moscow, Russia
[5] Russian Acad Sci, Karnakov Inst Gen & Inorgan Chem, Moscow, Russia
关键词
Amorphous solid dispersion; Differential scanning calorimetry; Dissolution testing; X-ray powder diffraction; Darunavir; Mesoporous silica; Magnesium aluminum silicate;
D O I
10.1016/j.ejps.2021.105700
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of this work was to compare mesopomus carriers based on silica and magnesium aluminosilicate in the amorphous solid dispersion production. Darunavir has been selected as an active pharmaceutical ingredient that is classified as a Class 2 BCS substance and exists in two commercially available forms: crystalline ethanolate and amorphous. In the course of the study, the conditions for the preparation of amorphous samples with the selected carriers were evaluated within the framework of the most common methods for obtaining solid dispersions - hot-melt extrusion, solvent wetting, and spray drying. It was determined that the obtained dispersion properties almost completely repeat the properties of the corresponding carriers. The resulting dispersions were examined in a dissolution test and the best ones was used to formulate tablets, which were studied in an in vitro dissolution test with the original Prezista. The proposed tablet formulation showed improved dissolution compared to the original one. It was also found that silica supports have a greater positive contribution to darunavir dissolution - both ethanolate or amorphous forms.
引用
收藏
页数:13
相关论文
共 50 条
[31]   Development of Orodispersible Tablets with Solid Dispersions of Fenofibrate and Co-Processed Mesoporous Silica for Improved Dissolution [J].
Baumgartner, Ana ;
Planinsek, Odon .
PHARMACEUTICS, 2024, 16 (08)
[32]   Solid-state characterization of Felodipine-Soluplus amorphous solid dispersions [J].
Lu, Jiannan ;
Cuellar, Kristina ;
Hammer, Nathan I. ;
Jo, Seongbong ;
Gryczke, Andreas ;
Kolter, Karl ;
Langley, Nigel ;
Repka, Michael A. .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2016, 42 (03) :485-496
[33]   Crystallinity: A Complex Critical Quality Attribute of Amorphous Solid Dispersions [J].
Moseson, Dana E. ;
Taylor, Lynne S. .
MOLECULAR PHARMACEUTICS, 2023, 20 (10) :4802-4825
[34]   Mechanisms of increased bioavailability through amorphous solid dispersions: a review [J].
Schittny, Andreas ;
Huwyler, Jorg ;
Puchkov, Maxim .
DRUG DELIVERY, 2020, 27 (01) :110-127
[35]   Impact of incorporated drugs on material properties of amorphous solid dispersions [J].
Fluegel, Karsten ;
Schmidt, Katharina ;
Mareczek, Lena ;
Gaebe, Michael ;
Hennig, Robert ;
Thommes, Markus .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2021, 159 :88-98
[36]   A Mechanistic Model for Predicting the Physical Stability of Amorphous Solid Dispersions [J].
Ojo, Andrew Toye ;
Lee, Ping, I .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2021, 110 (04) :1495-1512
[37]   Preparation and Characterization of Amorphous Solid Dispersions of Nimesulide in Cyclodextrin Copolymers [J].
Skiba, M. ;
Lahiani-Skiba, M. ;
Milon, N. ;
Bounoure, F. ;
Fessi, H. .
JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY, 2014, 14 (04) :2772-2779
[38]   Formulation Characterization and Pharmacokinetic Evaluation of Amorphous Solid Dispersions of Dasatinib [J].
Dharani, Sathish ;
Mohamed, Eman M. ;
Khuroo, Tahir ;
Rahman, Ziyaur ;
Khan, Mansoor A. .
PHARMACEUTICS, 2022, 14 (11)
[39]   Supersaturation and phase behavior during dissolution of amorphous solid dispersions [J].
Kong, Yang ;
Wang, Wenhan ;
Wang, Changzhao ;
Li, Lintao ;
Peng, Donglei ;
Tian, Bin .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2023, 631
[40]   Polymeric Amorphous Solid Dispersions of Dasatinib: Formulation and Ecotoxicological Assessment [J].
Sokac, Katarina ;
Miloloza, Martina ;
Kucic Grgic, Dajana ;
Zizek, Krunoslav .
PHARMACEUTICS, 2024, 16 (04)